Insiders / Fonteyne Paul R.

Fonteyne Paul R.

CIK 1727550personinsider

Companies

First seen

Jan 5, 2026

Last activity

Jan 5, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Apellis Pharmaceuticals, Inc. · APLS	Director	30,666	30,666	2	—

2 positions · latest reported per filing

Company	Security	Shares	As of
Apellis Pharmaceuticals, Inc.	Common Stock	30,666	Jan 1, 2026
Apellis Pharmaceuticals, Inc.	Stock Option (Right to Buy)Derivative	14,684	Jan 1, 2026

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Jan 1, 2026	Grant	APLS Apellis Pharmaceuticals, Inc. Common Stock	$0	+8K +35.06%	30,666 0.02% of shares	low
Jan 1, 2026	Grant	APLS Apellis Pharmaceuticals, Inc. Stock Option (Right to Buy)	—	+15K	14,684 0.01% of shares	low